Wave Life Sciences Ltd Asset Turnover Ratio (WVE), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Wave Life Sciences Ltd   (NASDAQ: WVE)
 

Wave Life Sciences Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Wave Life Sciences Ltd asset turnover ratio, the ability of Wave Life Sciences Ltd 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.2 in the first quarter (Mar 31 2026), yet the ratio remained below the average, as WVE's position remain challenging.

Within sector 9 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 184 to 308.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WVE Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 103.7 % 91 % -29.25 % 33.11 % 33.55 %
Y / Y Revenue Change 316.85 % -59.86 % - -55.82 % -26.82 %
Asset Turnover Ratio (TTM) 0.2 0.17 0.39 0.31 0.36
WVE's Total Ranking # 308 # 184 # 1650 # 2430 #
Seq. Asset Change -8.55 % 166.1 % -4.35 % -12.48 % -14.26 %
Seq. Revenue Change 13.76 % 341.9 % -12.54 % -5.19 % -89.04 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 31
Overall Market # 308

Asset Turnover Ratio Statistics
High Average Low
159.74 23.31 0.65
(Dec 31 2024)   (Sep 30 2020)




WVE Company Profile • Back to WVE Efficiency Comparisons • Compare WVE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Rxsight Inc   0.41 $ 127.178  Millions$ 308.337  Millions
Amgen Inc   0.41 $ 37,220.000  Millions$ 90,282.000  Millions
Kestra Medical Technologies Ltd   0.41 $ 93.819  Millions$ 229.353  Millions
Tenon Medical Inc   0.41 $ 4.597  Millions$ 11.270  Millions
Vanda Pharmaceuticals Inc   0.41 $ 217.782  Millions$ 537.090  Millions
Dyadic International Inc   0.41 $ 3.808  Millions$ 9.392  Millions
Syndax Pharmaceuticals Inc   0.40 $ 217.174  Millions$ 537.579  Millions
Bausch Health Companies Inc   0.40 $ 10,531.000  Millions$ 26,238.500  Millions
Medtronic Plc  0.40 $ 36,364.000  Millions$ 91,756.500  Millions
Becton Dickinson And Company  0.39 $ 21,366.000  Millions$ 54,096.000  Millions
Zai Lab Limited  0.39 $ 453.280  Millions$ 1,147.791  Millions
Alpha Teknova Inc   0.39 $ 41.206  Millions$ 105.088  Millions
Bionano Genomics Inc   0.39 $ 28.738  Millions$ 73.365  Millions
Arrowhead Pharmaceuticals Inc   0.39 $ 622.009  Millions$ 1,604.867  Millions
Jazz Pharmaceuticals Plc  0.39 $ 4,438.645  Millions$ 11,454.892  Millions
Viatris Inc   0.39 $ 14,562.600  Millions$ 37,589.900  Millions
Harvard Apparatus Regenerative Technology Inc   0.39 $ 0.885  Millions$ 2.290  Millions
Waters Corporation  0.38 $ 3,770.581  Millions$ 9,797.047  Millions
Cardiff Lexington Corporation  0.38 $ 10.842  Millions$ 28.375  Millions
Immunocore Holdings Plc  0.38 $ 412.812  Millions$ 1,081.063  Millions
Assertio Holdings inc   0.38 $ 102.158  Millions$ 267.956  Millions
Intelligent Bio Solutions Inc   0.38 $ 3.913  Millions$ 10.350  Millions
Schrodinger Inc   0.38 $ 254.905  Millions$ 675.563  Millions
Bausch and Lomb Corp  0.38 $ 5,208.000  Millions$ 13,866.500  Millions
Regeneron Pharmaceuticals Inc   0.37 $ 14,919.600  Millions$ 39,954.025  Millions
Veracyte Inc   0.37 $ 516.183  Millions$ 1,388.578  Millions
Sotera Health Company  0.37 $ 1,188.171  Millions$ 3,225.495  Millions
Xilio Therapeutics Inc   0.37 $ 53.484  Millions$ 146.420  Millions
Zimmer Biomet Holdings Inc   0.36 $ 8,409.100  Millions$ 23,041.600  Millions
Meiragtx Holdings Plc  0.36 $ 79.758  Millions$ 219.318  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.